Market Place
Sourcing Support
Shilpa Medicare Falls After FDA Issues 4 Observations at Facility
31 Oct 2024 //
BUSINESS STD
Amneal and Shilpa Announce FDA Approval Of BORUZU, Ready-to-Use
05 Sep 2024 //
BUSINESSWIRE
Shilpa Medicare Completes Phase 1 Trial For Recombinant Albumin
28 Aug 2024 //
PR NEWSWIRE
Shilpa Medicare Completes Phase-3 Trial For Nonalcoholic Fatty Liver Disease
26 Aug 2024 //
ECONOMICTIMES
Shilpa Pharma Unit 2 Raichur Clears ANVISA-Brazil GMP Inspection
10 Jul 2024 //
INDIANPHARMAPOST
Shilpa`s CDMO customer placed binding purchase order
08 Jul 2024 //
INDIAPHARMAPOST
Shilpa Biologicals files Type IV DMF of recombinant Human Albumin 20% with USFDA
05 Jun 2024 //
INDIANPHARMAPOST
Shilpa Medicare launches Pemetrexed injection
19 Apr 2024 //
INDINPHARMAPOST
Shilpa Medicare gets Europe approval for Varenicline Tablets, 0.5mg and 1mg
26 Feb 2024 //
INDIAN PHARMA POST
Shilpa Medicare directed to to pay damage to Celltrion
25 Jan 2024 //
INDIAN PHARMA POST
Shilpa Medicare shares up 2% on acquiring US-based Pilnova Pharma
03 Nov 2023 //
MONEY CONTROL
Shilpa Medicare launches `Oraal’ for treatment of oral mucositis
13 Oct 2023 //
INDIAN PHARMA POST
Shilpa Medicare receives MHRA approval for mouth-dissolving strips
03 Sep 2023 //
INDIAN PHARMA POST
Shilpa Medicare launches Lenvatinib Capsules in India under the brand Lenshil
30 Jun 2023 //
INDIAN PHARMA POST
Shilpa`s Generic Apremilast Receives Approval in the U.S.
07 Apr 2023 //
FDA
Shilpa Medicare introduces cancer drug Capecitabine 1000 MG dispersible tablet
19 Dec 2022 //
INDIANPHARMAPOST
Shilpa Medicare introduces cancer drug Capecitabine 1000 MG dispersible tablet
19 Dec 2022 //
INDIANPHARMAPOST
Briefs: Piramal Enterprises and Shilpa Medicare
02 Dec 2022 //
INDIAPHARMAPOST
Shilpa Medicare Hyderabad facility receives US FDA clearance
23 Sep 2022 //
INDIANPHARMAPOST
Shilpa Medicare arm gets NoC to conduct clinical studies forAflibercept
26 Apr 2022 //
ECONOMICTIMES
Shilpa Medicare to make Cadila`s Covid-19 vaccine
23 Sep 2021 //
DECCANHERALD
Steriline Supplies Shilpa Medicare with Pilot Line for Injectable Oncology Drugs
20 Jul 2021 //
CONTRACT PHARMA
Shilpa Medicare Joins Dr. Reddy`s to Manufacture 5 Crore Doses of Sputnik V
17 May 2021 //
NEWS18
Shilpa Pharma sues Novartis Pharmaceutical Corporation for patent infringement
28 Apr 2021 //
THEHINDUBUSINESSLINE
India`s Shilpa Medicare can make 100-200 million doses of COVID-19 shot,
06 Apr 2021 //
INDIATIMES
Shilpa Medicare gets tentative American health regulator nod for Apremilast tab
05 Mar 2021 //
ECONOMIC TIMES
Shilpa Medicare Limited on FDA Imprt Alert List
17 Feb 2021 //
FDA
US FDA Import Alert takes its toll on Shilpa Medicare
17 Feb 2021 //
BUSINESS-STANDARD
Shilpa Medicare on Health Canada Inspection List
23 Dec 2020 //
HEALTH CANADA
Enforcement Report - Week of December 16, 2020
16 Dec 2020 //
FDA
USFDA issues warning to Shilpa Medicare for CGMP violations at Telangana plant
30 Oct 2020 //
ECONOMICTIMES
FDA Reveals Details Of Shilpa’s Violations
30 Oct 2020 //
PHARMAINTELLIGENCE.INFORMA
Shilpa Medicare Limited Receives FDA Warning Letter
28 Oct 2020 //
FDA
Shilpa Medicare slips 12% on USFDA warning letter for Telangana facility
12 Oct 2020 //
BUSINESS-STANDARD
Shilpa Medicare gains 5% on launch of generic drug for kidney cancer
29 Jun 2020 //
MONEYCONTROL
Shilpa Medicare launches Ibrushil for leukaemia treatment
28 May 2020 //
PHARMABIZ
Shilpa Medicare launches branded generic anticancer drug Dasatinib
23 Apr 2020 //
PHARMABIZ
Shilpa Medicare’s Raichur API unit gets EIR from US FDA
20 Apr 2020 //
PHARMABIZ
Shilpa Medicare`s subsidiary gets UK regulator nod for anti-cancer drug
06 Apr 2020 //
MONEYCONTROL
FDA issues form 483 to Shilpa Medicare Ltd.
03 Apr 2020 //
FDA
Shilpa Medicare hits fresh 52-week high; stock zooms 89% in a month
24 Feb 2020 //
BUSINESS-STANDTARD
Shilpa Medicare Launches Breakthrough Therapy Lenvatinib Mesylate
03 Feb 2020 //
BUSINESS
Shilpa Medicare`s Generic Pirfenidone Receives Tentative Approval in US
31 Jan 2020 //
FDA
Shilpa Medicare gets EIR from USFDA for Raichur facility
03 Dec 2019 //
MONEY CONTROL
Shilpa Medicare`s Generic Erlotinib Hydrochloride Receives Approval in US
07 Nov 2019 //
FDA
Shilpa Medicare receives EIR from US FDA for Jadcherla unit
25 Oct 2019 //
PHARMABIZ
Shilpa Medicare`s Generic Gemcitabine Hydrochloride Receives Approval in US
09 Oct 2019 //
FDA
FDA Issues Form 483 to Shilpa Medicare Limited
23 Aug 2019 //
FDA
Shilpa Medicare`s Generic Docetaxel Receives Approval in US
21 May 2019 //
FDA
Shilpa Medicare`s Generic Zoledronic Acid Receives Approval in US
20 May 2019 //
FDA
Shilpa Medicare gets USFDA nod for cancer drug
17 May 2019 //
ECONOMIC TIMES
Shilpa Medicare`s Generic Busulfan Receives Approval in US
23 Apr 2019 //
FDA
Shilpa Medicare`s Generic Bortezomib Receives Tentative Approval in US
10 Apr 2019 //
FDA
Shilpa Medicare`s Generic Irinotecan Hydrochloride Receives Approval in US
01 Jan 2019 //
FDA
Shilpa Medicare`s Generic Irinotecan Hydrochloride Receives Approval in US
31 Dec 2018 //
FDA
Imbruvica (Ibrutinib) : Pharmacyclics, Janssen Biotech vs. Sun Pharma Global
19 Oct 2018 //
PATENT LITIGATION
Tarceva¨ (erlotinib HCl): OSI Pharmaceuticals et al v. Shilpa Medicare Limited
26 Jul 2018 //
PATENT LITIGATION
Otezla (apremilast): Celgene Corporation v. Shilpa Medicare Ltd.
29 Jun 2018 //
PATENT LITIGATION
FDA Issues Form 483 to Shilpa Medicare
31 Jan 2018 //
FDA
